
Young kids, babies are getting into nicotine pouches. What parents should know.
The warning comes amid new research showing calls that involved children under 6 increased by 763% from 2020 to 2023, according to the study published July 14 in the journal Pediatrics.
The steep increase in calls to poison control centers is partly due to the rising popularity of nicotine pouches, said Natalie Rine, study co-author and director of the Central Ohio Poison Center. Children were also home more during this period as the pandemic prompted stay-at-home orders, which gave them more access to nicotine products stored in the house.
'The popularity of these products started in 2019,' she said. 'There was a large increase in sales between 2019 and 2022… and we started getting calls more frequently.'
Nicotine pouches, sometimes referred to as "lip pillow" or "upper decker," are small microfiber pouches containing nicotine powder. Here's what parents should know about keeping their kids safe from nicotine pouches.
'Nicotine hiccups': What are they and why do they happen?
How is nicotine dangerous to kids?
Nicotine pouches were 1.5 times more likely to be associated with a serious medical outcome and twice as likely to be associated with a medical admission compared to any other nicotine product included in the study, such as cigarettes or liquid nicotine.
Nicotine is a highly toxic substance to young children, especially in a concentrated form like a nicotine pouch, according to Nationwide Children's Hospital in Columbus, Ohio.
FDA seeks to limit nicotine in cigarettes, most cigars. Vapes and Zyn are excluded.
After ingestion, some minor symptoms can include nausea and vomiting, Rine said. But as the dose increases, children can experience high blood pressure and a fast heart rate, which can escalate to seizures and respiratory failure.
Among the 135,000 calls made to poison control centers between 2010 and 2023, study authors found that nicotine was linked to two deaths in children under 6.
How to prevent an emergency
The best way to prevent a child from ingesting a nicotine pouch is to keep products out of the house, Rine said.
If parents or guardians choose to keep nicotine products at home, she recommends they take the following precautions:
What to do if your kid swallows a nicotine pouch
If a child is experiencing a medical emergency, Rine urges parents to call 911.
If they're showing mild symptoms, she recommends calling the national Poison Help Line to access free, confidential expert advice from specially trained nurses and pharmacists.
'We're always there to help talk you through what symptoms you're seeing with the child, based on the history that's given,' Rine said.
She warns against trying to induce vomiting, as that can lead to a secondary problem if fluid enters the lungs.
'Inducing vomiting is one of the bigger misconceptions that's out there,' Rine said. 'More often than not, you have the potential to cause more of a problem than what you're already dealing with.'
Adrianna Rodriguez can be reached at adrodriguez@usatoday.com.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Popular yogurt recalled nationwide due to possible plastic pieces
Danone U.S., the maker of YoCrunch, is recalling the yogurt product due to the potential presence of plastic pieces in the packaging's dome topper, according to federal health officials. In an alert, the U.S. Food and Drug Administration said the plastic pieces, which were discovered after reported consumer complaints, could potentially cause a choking response if eaten. "The plastic pieces are transparent, may have sharp edges, and could present a risk to consumers because some pieces are between 7 and 25 mm in length," the FDA noted. "The issue is isolated only to the separately packaged topper and does not impact the separately packaged yogurt." This recall applies to all flavors and sizes of YoCrunch products currently in market at retail stores nationwide, including those with toppers containing granola, cookie dough, Oreo, M&M, Snickers and Twix pieces. A full list of impacted product names and code dates is on the FDA's website. "The company is working swiftly with retail partners to remove the impacted product from shelves," the FDA said. For information on refunds, consumers can contact the YoCrunch consumer care line at 1-877-344-4886. Sen. Lindsey Graham says "a turning point regarding Russia's invasion of Ukraine is coming" Trump pushes senators to make $9.4 trillion in spending cuts Watch: Waltz makes case to be U.N. ambassador after Trump administration ousting


CBS News
an hour ago
- CBS News
YoCrunch yogurt products recalled nationwide due to potential presence of plastic pieces
Danone U.S., the maker of YoCrunch, is recalling the yogurt product due to the potential presence of plastic pieces in the packaging's dome topper, according to federal health officials. In an alert, the U.S. Food and Drug Administration said the plastic pieces, which were discovered after reported consumer complaints, could potentially cause a choking response if eaten. "The plastic pieces are transparent, may have sharp edges, and could present a risk to consumers because some pieces are between 7 and 25 mm in length," the FDA noted. "The issue is isolated only to the separately packaged topper and does not impact the separately packaged yogurt." This recall applies to all flavors and sizes of YoCrunch products currently in market at retail stores nationwide, including those with toppers containing granola, cookie dough, Oreo, M&M, Snickers and Twix pieces. A full list of impacted product names and code dates is on the FDA's website. "The company is working swiftly with retail partners to remove the impacted product from shelves," the FDA said. For information on refunds, consumers can contact the YoCrunch consumer care line at 1-877-344-4886.


Fox News
an hour ago
- Fox News
New weekly injection for Parkinson's could replace daily pill for millions, study suggests
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for daily pills. Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that provides two key Parkinson's medications for an entire week. There is currently no cure for Parkinson's, which is the second-most common neurological disorder, affecting more than one million Americans, according to the Parkinson's Foundation. To manage symptoms like tremors, rigidity and slow movement, patients typically take daily oral medications, such as levodopa and carbidopa, according to the university's press release. This method can be especially difficult for individuals who have trouble swallowing or are otherwise unable to take the pills consistently, leading to irregular medication levels, increased side effects and reduced effectiveness. Levodopa is the "gold-standard therapy for Parkinson's," according to lead researcher Professor Sanjay Garg at UniSA, but its short lifespan means it must be taken several times a day. The researchers tested an injectable gel implant that combines an FDA-approved biodegradable substance with a pH-sensitive substance to achieve a controlled and sustained drug release. The gel is injected through a single shot under the skin or into the muscle tissue, which means there's no need for a surgical implant and discomfort is minimal, they noted. The team found that the gel gradually released the key Parkinson's medications (90% of the levodopa drug and 81% of the carbidopa) over the course of one week. The findings were published in the journal Drug Delivery and Translational Research. "Reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy," Garg said in the release. "We're not just improving how the drug is delivered; we're improving patients' lives." Extensive lab tests confirmed the system's effectiveness and safety. "We're not just improving how the drug is delivered; we're improving patients' lives." The implant degraded by over 80% within a week and showed no significant toxicity in cell viability tests. "The implications of this research are profound," Garg added. Deepa Nakmode, a PhD student at the University of South Australia, noted that this method is designed to release both levodopa and carbidopa steadily over one week, maintaining consistent plasma levels and reducing the risks associated with fluctuating drug concentrations. "After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage," he said in the release. The team's invention has now been filed for an Australian patent, Nakmode added. The technology could also be adapted for other chronic conditions, such as cancer, diabetes, neurodegenerative disorders, chronic pain and infections that require long-term drug delivery, according to Garg. The system can be tuned to release drugs over a period ranging from a few days to several weeks, depending on therapeutic needs. For more Health articles, visit Scientists hope to start clinical trials in the near future and are exploring opportunities to make the gel commercially available.